Most Cannabinoid Hyperemesis Syndrome Patients Resume Cannabis Use Within Days of an ER Visit
After an emergency department visit for cannabinoid hyperemesis syndrome, most patients temporarily reduced cannabis use but returned to pre-visit patterns within days, and 25% made repeat ER visits within three months.
Quick Facts
What This Study Found
Participants had persistent CHS symptoms (abdominal pain, nausea, cyclic vomiting) for a median of 7 days after their ED visit. Cannabis use frequency and quantity were reduced immediately after the visit but most returned to pre-visit use patterns within days. 25% of those who completed follow-up had recurrent ED visits within 3 months.
Key Numbers
39 patients enrolled. Median symptom persistence: 7 days post-ED visit. 25% had recurrent ED visits within 3 months. Most returned to pre-visit cannabis use patterns within days of the ED visit.
How They Did This
Prospective observational cohort of 39 patients with suspected CHS recruited from the ED during symptomatic episodes and followed for 3 months. Cannabis use practices, symptom progression, and healthcare utilization were monitored.
Why This Research Matters
CHS is increasingly common as cannabis use rises, yet almost nothing is known about what happens after patients leave the ER. This study reveals a cycle of temporary reduction followed by rapid return to use, with ongoing symptoms managed at home, suggesting current ED-based interventions are insufficient to change behavior.
The Bigger Picture
CHS is a growing challenge in emergency medicine and represents a unique form of cannabis-related harm that directly contradicts the perception of cannabis as universally low-risk. The rapid return to use despite symptoms suggests that CHS patients may need sustained outpatient support, not just acute ED care.
What This Study Doesn't Tell Us
Small sample size (n=39) limits generalizability. CHS diagnosis was based on clinical suspicion without universally agreed-upon diagnostic criteria. Three-month follow-up may be too short to capture longer-term outcomes.
Questions This Raises
- ?What interventions at the ED visit would most effectively support sustained cannabis reduction?
- ?Does CHS severity worsen with repeated cycles of use and ED visits over longer timeframes?
Trust & Context
- Key Stat:
- 25% of CHS patients had repeat ER visits within 3 months
- Evidence Grade:
- Preliminary: prospective design with longitudinal follow-up addresses a major knowledge gap, but the small sample (n=39) limits statistical power and generalizability.
- Study Age:
- 2024 study.
- Original Title:
- Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.
- Published In:
- Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 31(5), 463-470 (2024)
- Authors:
- Wightman, Rachel S(5), Metrik, Jane(16), Lin, Timmy R(3), Collins, Alexandra B, Beaudoin, Francesca L
- Database ID:
- RTHC-05816
Evidence Hierarchy
Enrolls participants and follows them forward in time.
What do these levels mean? →Frequently Asked Questions
What is cannabinoid hyperemesis syndrome?
CHS is a condition of severe cyclic vomiting, nausea, and abdominal pain caused by chronic cannabis use. It typically resolves when cannabis use stops but recurs when use resumes. Hot showers or baths often temporarily relieve symptoms.
Why do patients resume cannabis use despite symptoms?
The study did not fully explore motivations, but cannabis use disorder, symptom management for other conditions, and the temporary relief that follows stopping may all contribute. The rapid return to use suggests CHS patients may benefit from structured cannabis use disorder treatment.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-05816APA
Wightman, Rachel S; Metrik, Jane; Lin, Timmy R; Collins, Alexandra B; Beaudoin, Francesca L. (2024). Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 31(5), 463-470. https://doi.org/10.1111/acem.14773
MLA
Wightman, Rachel S, et al. "Cannabinoid hyperemesis syndrome: Clinical trajectories and patterns of use three months following a visit to the emergency department.." Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2024. https://doi.org/10.1111/acem.14773
RethinkTHC
RethinkTHC Research Database. "Cannabinoid hyperemesis syndrome: Clinical trajectories and ..." RTHC-05816. Retrieved from https://rethinkthc.com/research/wightman-2024-cannabinoid-hyperemesis-syndrome-clinical
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.